NRGN and Alzheimer disease: As blood neural cell-derived sEVs reflect changes in brain tissue itself, their results are consistent with the changes in brain tissue, while studies have shown that neurogranin in the blood of patients with AD is unchanged [98,101], which may be related to the dilution of synaptic proteins after they are introduced into peripheral blood, and the specific reasons remain to be further confirmed.